IP Industries – Pharma

Our lawyers are scientists. We speak your language.

The Fox IP team includes attorneys with advanced degrees in biophysics, biotechnology, chemistry, human genetics, immunology, inorganic chemistry, molecular biology, molecular genetics, microbiology, organic chemistry, polymer science and virology.

We provide the strategy for protecting and profiting from pharmaceutical patents.


  • Warner Chilcott Company, LLC v. Lupin, Ltd. et al.
    Court ruled in favor of our client that the evidence of prima facie obviousness was strong and invalidated the chewable oral contraceptives patent number 6,667,050.
  • Tyco Healthcare Group LP et al v. Pharmaceutical Holdings Corporation et al.
    Court granted summary judgment in favor of our client’s claim of prima facie obviousness. The case was appealed to the Federal Circuit.
  • Teva Women's Health, Inc. v. Lupin, Ltd.
    Court held in favor of our client that the evidence of prima facieobviousness was strong and invalidated the patent. The case was appealed to the Federal Circuit.
  • Astrazeneca Pharmaceuticals LP et al v. Lupin Ltd. et al.
    Settled case on terms favorable for our client.
  • Astrazeneca AB et al v. Dr. Reddy's Laboratories Inc. et al.
    Settled case on terms favorable for our client.
  • Gilead Sciences, Inc. v. Sigmapharm Laboratories, LLC
    Settled case on terms favorable for our client.
  • The Medicines Company v. Teva Parenteral Medicines, Inc.
    Served as Special Master to the Court.
  • Novartis Pharmaceuticals Corporation v. Actavis LLC
  • Horizon Pharma AG et al v. Watson Laboratories, Inc.- Florida et al.
  • Novartis Pharmaceuticals Corporation et al v. Wockhardt USA LLC et al.
  • Everett Laboratories, Inc. v. Acella Pharmaceuticals, LLC
    Defeated three motions for a preliminary injunction in a pharmaceutical patent case involving prenatal nutritional supplements, which led to the withdrawal of the remaining motion for a preliminary injunction.

Trade Secrets

  • Prosecuted claims for misappropriation of trade secrets for a global pharmaceutical company against its former executive. After preliminary forensic investigation of laptop and mobile phones, former executive consented to an injunction.


  • Handled extensive trademark clearance and prosecution for the infant care division of a multinational pharmaceutical company.
  • Merck & Co., Inc. v. Vioxx Corporation
    Served as lead counsel for Merck in settled case involving the pharmaceutical trademark Vioxx.